NCT03095235View on ClinicalTrials.gov

Dietary Riboflavin (Vitamin B-2) and Cornea Cross-Linking

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 1, 2025

Study Completion Date

July 1, 2025

Conditions
KeratoconusCornea Ectasia
Interventions
DIETARY_SUPPLEMENT

Dietary riboflavin

Dietary riboflavin is vitamin B2. It has been shown to be safe in children in the treatment of migraines at doses of 400 mg per day. There are no known documented side effects

Trial Locations (1)

33612

RECRUITING

University of South Florida Department of Ophthalmology, Tampa

All Listed Sponsors
collaborator

University of South Florida

OTHER

lead

University of Missouri-Columbia

OTHER